Tuberculosis after conversion from azathioprine to mycophenolate mofetil in a long-term renal transplant recipient

被引：17
|
作者：
Mercadal, L [1 ]
Foltz, V [1 ]
Isnard-Bagnis, C [1 ]
Ourahma, S [1 ]
Deray, G [1 ]
机构：
[1] Hop La Pitie Salpetriere, Dept Nephrol, F-75013 Paris, France
来源：
TRANSPLANTATION PROCEEDINGS | 2005年 / 37卷 / 10期
关键词：
D O I：
10.1016/j.transproceed.2005.11.010
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We report the third case in the literature of a patient with a long-lasting renal allograft who experienced tuberculosis just after the switch from azathioprine to mycophenolate mofetil. The switch was likely responsible for the reactivation of dormant tuberculosis; prophylactic antituberculous treatment should be considered in cases of such a therapeutic change.
引用
收藏
页码：4241 / 4243
页数：3
相关论文
共 50 条
  • [31] Oral ulcers associated with mycophenolate mofetil use in a renal transplant recipient
    Weng, Renee R.
    Foster, Clarence E., III
    Hsieh, Lanny L.
    Patel, Puja R.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (07) : 585 - 588
  • [32] Ulcers of the mouth in a renal transplant recipient:: the role of mycophenolate mofetil (Cellcept®)
    Schmutz, JL
    Barbaud, A
    Trechot, P
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2003, 130 (02): : 241 - 241
  • [33] Long-term benefits of mycophenolate mofetil after heart transplantation
    Keogh, A
    TRANSPLANTATION, 2005, 79 (03) : S45 - S46
  • [34] Short- and Long-Term Outcomes of Mycophenolate Versus Azathioprine in a Large Cohort of Renal Transplant Recipients
    Bowman, L.
    Horwedel, T.
    Hagopian, J.
    Brennan, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [35] Mycophenolate mofetil maintenance therapy in renal transplant patients: long-term results of the TranCept STAY study
    Heemann, Uwe
    Kliem, Volker
    Budde, Klemens
    Hamza, Amir
    Juergensen, Jan Steffen
    Juarez, Federico
    Arns, Wolfgang
    Rath, Thomas
    Haller, Hermann
    CLINICAL TRANSPLANTATION, 2012, 26 (06) : 919 - 926
  • [36] Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients
    Kovarik, JM
    Pescovitz, MD
    Sollinger, HW
    Kaplan, B
    Legendre, C
    Salmela, K
    Book, BK
    Gerbeau, C
    Girault, D
    Somberg, K
    CLINICAL TRANSPLANTATION, 2001, 15 (02) : 123 - 130
  • [37] Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients
    Meier-Kriesche, HU
    Morris, JA
    Chu, AH
    Steffen, BJ
    Gotz, VP
    Gordon, RD
    Kaplan, B
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (11) : 2864 - 2869
  • [38] Mycophenolate mofetil versus azathioprine therapy is a associated with a significant protection against long-term renal allograft function deterioration
    Meier-Kriesche, HU
    Steffen, BJ
    Hochberg, AM
    Gordon, RD
    Liebman, MN
    Morris, JA
    Kaplan, B
    TRANSPLANTATION, 2003, 75 (08) : 1341 - 1346
  • [39] Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?
    Johnson, DW
    Nicol, DL
    Purdie, DM
    Preston, JM
    Brown, AM
    Hawley, CM
    Campbell, SB
    Wall, D
    Griffin, AD
    Isbel, NM
    TRANSPLANTATION, 2002, 73 (07) : 1158 - 1163
  • [40] RENAL ONCOCYTOMA IN A LONG-TERM RENAL-TRANSPLANT RECIPIENT
    COFAN, F
    PARRA, E
    SOLE, M
    RICART, MJ
    OPPENHEIMER, F
    CAMPISTOL, JM
    VILARDELL, J
    CARRETERO, P
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (04) : 560 - 562
12345